Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
has not yet received the 2nd one; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose in July 2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: has not yet received the 2nd one). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 28-FEB-2025 The pharmacist reported that the patient had not yet received the 2nd one. The vaccine administration facility was the same as primary reporter. The reporter stated follow-up via postal. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.